NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.57
Delayed Data
As of Feb 16
 +0.02 / +0.56%
Today’s Change
2.25
Today|||52-Week Range
5.00
-7.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash10.5M5.4M2.4M9.5M
 
 
 
 
 
Short Term Investment Cash-2.2M-5.1M-3.0M7.1M
 
 
 
 
 
Cash & Short Term Investments13.1M5.4M2.4M9.5M
 
 
 
 
 
 
ReceivablesReceivables784.0K273.0K536.0K2.1M
 
 
 
 
 
 
InventoriesInventories231.0K521.0K1.3M873.0K
 
 
 
 
 
 
Current AssetsOther Current Assets723.0K729.0K261.0K2.0M
 
 
 
 
 
Current Assets14.8M7.0M4.5M14.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.4M2.0M2.1M520.0K
 
 
 
 
 
Depreciation-1.6M-1.5M-1.7M-149.0K
 
 
 
 
 
Other Assets141.0K149.0K155.0K539.0K
 
 
 
 
 
Total Assets15.7M7.5M5.1M15.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.7M1.9M2.5M455.0K
 
 
 
 
 
Accrued Expenses767.0K388.0K776.0K1.8M
 
 
 
 
 
Other Current Liabilities1.1M813.0K946.0K3.9M
 
 
 
 
 
Other Liabilities3.6M3.3M4.6M4.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.001.7M0.00
 
 
Other Liabilities1.8M173.0K1.6M2.0M
 
 
 
 
 
Total Liabilities7.1M5.7M10.2M8.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity8.5M1.8M-5.1M7.1M
 
 
 
 
 
Total Shareholder Equity8.5M1.8M-5.1M7.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding1.8M2.1M3.5M15.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.